Misonix (MSON) Downgraded by TheStreet to D
Shares of Misonix (MSON) opened at $10.25 on Friday. Misonix has a 12-month low of $7.05 and a 12-month high of $12.00.
Institutional investors have recently made changes to their positions in the company. Keybank National Association OH purchased a new stake in shares of Misonix during the 4th quarter valued at $109,000. Northern Trust Corp increased its position in shares of Misonix by 2.5% during the 2nd quarter. Northern Trust Corp now owns 24,378 shares of the medical equipment provider’s stock valued at $233,000 after purchasing an additional 591 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in shares of Misonix by 0.9% during the 2nd quarter. Vanguard Group Inc. now owns 106,353 shares of the medical equipment provider’s stock valued at $1,027,000 after purchasing an additional 900 shares during the last quarter. 10.34% of the stock is owned by hedge funds and other institutional investors.
Misonix, Inc designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company’s products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties.
Receive News & Ratings for Misonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Misonix and related companies with MarketBeat.com's FREE daily email newsletter.